Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 9
1947 11
1948 4
1949 5
1950 27
1951 47
1952 10
1953 16
1954 10
1955 13
1956 8
1957 6
1958 7
1959 12
1960 5
1961 9
1962 17
1963 217
1964 434
1965 285
1966 227
1967 240
1968 304
1969 349
1970 393
1971 459
1972 436
1973 510
1974 497
1975 469
1976 484
1977 442
1978 409
1979 431
1980 413
1981 408
1982 390
1983 454
1984 505
1985 540
1986 518
1987 500
1988 474
1989 464
1990 466
1991 471
1992 477
1993 449
1994 406
1995 474
1996 441
1997 468
1998 471
1999 476
2000 506
2001 556
2002 605
2003 663
2004 588
2005 653
2006 750
2007 909
2008 897
2009 934
2010 1141
2011 1170
2012 1372
2013 1356
2014 1632
2015 1561
2016 1578
2017 1636
2018 1597
2019 1841
2020 1869
2021 1766
2022 1579
2023 1420
2024 864

Text availability

Article attribute

Article type

Publication date

Search Results

41,729 results

Results by year

Filters applied: . Clear all
Page 1
EASL Clinical Practice Guidelines: Drug-induced liver injury.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27. J Hepatol. 2019. PMID: 30926241
This makes the diagnosis of drug-induced liver injury an uncertain process, requiring a high degree of awareness of the condition and the careful exclusion of alternative aetiologies of liver disease. ...These Clinical Practice Guidelines summar …
This makes the diagnosis of drug-induced liver injury an uncertain process, requiring a high degree of awareness …
Drug-induced liver injury.
Katarey D, Verma S. Katarey D, et al. Clin Med (Lond). 2016 Dec;16(Suppl 6):s104-s109. doi: 10.7861/clinmedicine.16-6-s104. Clin Med (Lond). 2016. PMID: 27956449 Free PMC article. Review.
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the western world. ...In view of the poor transplant-free survival in idiosyncratic DILI, early consideration for liver transplant is mandatory
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the wester
Incidence and risk factors of drug-induced liver injury.
Li X, Tang J, Mao Y. Li X, et al. Liver Int. 2022 Aug;42(9):1999-2014. doi: 10.1111/liv.15262. Epub 2022 Apr 2. Liver Int. 2022. PMID: 35353431 Review.
The epidemiology and aetiology of drug-induced liver injury (DILI) vary across different countries and populations. ...Some factors may contribute to the risk of DILI in a drug-specific manner....
The epidemiology and aetiology of drug-induced liver injury (DILI) vary across different countries and populatio …
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK, Björnsson ES. Björnsson HK, et al. Eur J Intern Med. 2022 Mar;97:26-31. doi: 10.1016/j.ejim.2021.10.035. Epub 2021 Nov 9. Eur J Intern Med. 2022. PMID: 34772600 Review.
Drug-induced liver injury (DILI) is an important but rare adverse event which can range from mild liver enzyme elevations to liver failure, transplantation or death. A large proportion of commonly used medications, in addition to herbal a
Drug-induced liver injury (DILI) is an important but rare adverse event which can range from mild liver e
Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity.
Saran C, Brouwer KLR. Saran C, et al. Toxicol Pathol. 2023 Oct;51(7-8):405-413. doi: 10.1177/01926233231212255. Epub 2023 Nov 20. Toxicol Pathol. 2023. PMID: 37982363 Free PMC article. Review.
Drug-induced liver injury (DILI) remains a major concern in drug development from a patient safety perspective because it is the leading cause of acute liver failure. ...The development of advanced in vitro models and novel biomarkers tha
Drug-induced liver injury (DILI) remains a major concern in drug development from a patient safety perspe
Biomarkers of drug-induced liver injury.
McGill MR, Jaeschke H. McGill MR, et al. Adv Pharmacol. 2019;85:221-239. doi: 10.1016/bs.apha.2019.02.001. Epub 2019 Mar 6. Adv Pharmacol. 2019. PMID: 31307588 Free PMC article. Review.
Drug-induced liver injury (DILI) is a major clinical and regulatory challenge. ...The purpose of this chapter is to review major advances in DILI biomarker research over the last decade, and to highlight some of the challenges involved in implementatio
Drug-induced liver injury (DILI) is a major clinical and regulatory challenge. ...The purpose of this chapter is
Mechanisms of Drug-Induced Hepatotoxicity.
Shehu AI, Ma X, Venkataramanan R. Shehu AI, et al. Clin Liver Dis. 2017 Feb;21(1):35-54. doi: 10.1016/j.cld.2016.08.002. Clin Liver Dis. 2017. PMID: 27842774 Review.
Drug-induced hepatotoxicity (DIH) is a significant cause of acute liver failure and liver transplantation. ...Certain risk factors associated with a drug and within an individual further predispose patients to DIH....
Drug-induced hepatotoxicity (DIH) is a significant cause of acute liver failure and liver transplantation
Animal models of drug-induced liver injury.
McGill MR, Jaeschke H. McGill MR, et al. Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):1031-1039. doi: 10.1016/j.bbadis.2018.08.037. Epub 2018 Sep 3. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31007174 Free PMC article. Review.
Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the most common cause of acute liver failure in the US. It is also one of the most common reasons for termination of new drugs during pr
Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the
Antioxidant-Based Preventive Effect of Phytochemicals on Anticancer Drug-Induced Hepatotoxicity.
Park JE, Ahn CH, Lee HJ, Sim DY, Park SY, Kim B, Shim BS, Lee DY, Kim SH. Park JE, et al. Antioxid Redox Signal. 2023 Jun;38(16-18):1101-1121. doi: 10.1089/ars.2022.0144. Epub 2023 Mar 8. Antioxid Redox Signal. 2023. PMID: 36242510 Review.
Significance: Drug-induced liver injury (DILI) or hepatotoxicity has been a hot issue to overcome on the safety and physiological function of the liver, since it is known to have biochemical, cellular, immunological, and molecular alterat …
Significance: Drug-induced liver injury (DILI) or hepatotoxicity has been a hot issue to overcome on the …
RUCAM in Drug and Herb Induced Liver Injury: The Update.
Danan G, Teschke R. Danan G, et al. Int J Mol Sci. 2015 Dec 24;17(1):14. doi: 10.3390/ijms17010014. Int J Mol Sci. 2015. PMID: 26712744 Free PMC article. Review.
RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver
RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences …
41,729 results
You have reached the last available page of results. Please see the User Guide for more information.